NOT FOR DISTRIBUTION
Header cover image

Market Cap

UK£161.0m

Last Updated

2021/04/20 18:46 UTC

Data Sources

Company Financials +

Executive Summary

Animalcare Group plc engages in the development, sale, and distribution of licensed veterinary pharmaceuticals; and identification of products and services to companion animal veterinary markets in Spain, Portugal, Germany, Italy, other European Union, Asia, the Middle East, Africa, the United Kingdom, Belgium, the Netherlands, and internationally. More Details


Snowflake Analysis

Flawless balance sheet and fair value.

Share Price & News

How has Animalcare Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ANCR is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: ANCR's weekly volatility (5%) has been stable over the past year.


Market Performance


7 Day Return

8.4%

ANCR

2.2%

GB Healthcare

-0.8%

GB Market


1 Year Return

53.5%

ANCR

50.3%

GB Healthcare

26.4%

GB Market

Return vs Industry: ANCR exceeded the UK Healthcare industry which returned 49.3% over the past year.

Return vs Market: ANCR exceeded the UK Market which returned 30.8% over the past year.


Shareholder returns

ANCRIndustryMarket
7 Day8.4%2.2%-0.8%
30 Day14.8%5.4%3.1%
90 Day42.6%12.3%3.6%
1 Year55.2%53.5%52.2%50.3%32.1%26.4%
3 Year43.9%35.5%-15.6%-19.8%13.6%0.2%
5 Yearn/a-22.7%-28.1%42.6%15.4%

Long-Term Price Volatility Vs. Market

How volatile is Animalcare Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Animalcare Group undervalued compared to its fair value and its price relative to the market?

41.5%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: ANCR (£2.71) is trading below our estimate of fair value (£4.63)

Significantly Below Fair Value: ANCR is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: ANCR is poor value based on its PE Ratio (695.6x) compared to the GB Healthcare industry average (31.8x).

PE vs Market: ANCR is poor value based on its PE Ratio (695.6x) compared to the UK market (26.5x).


Price to Earnings Growth Ratio

PEG Ratio: ANCR is poor value based on its PEG Ratio (15.9x)


Price to Book Ratio

PB vs Industry: ANCR is good value based on its PB Ratio (2x) compared to the GB Healthcare industry average (2.1x).


Future Growth

How is Animalcare Group forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

43.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ANCR's forecast earnings growth (43.8% per year) is above the savings rate (1%).

Earnings vs Market: ANCR's earnings (43.8% per year) are forecast to grow faster than the UK market (21% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: ANCR's revenue (5.2% per year) is forecast to grow slower than the UK market (6.2% per year).

High Growth Revenue: ANCR's revenue (5.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if ANCR's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Animalcare Group performed over the past 5 years?

-27.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ANCR has a large one-off loss of £1.9M impacting its December 31 2020 financial results.

Growing Profit Margin: ANCR became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: ANCR has become profitable over the past 5 years, growing earnings by -27.3% per year.

Accelerating Growth: ANCR has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: ANCR has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (15.3%).


Return on Equity

High ROE: ANCR's Return on Equity (0.3%) is considered low.


Financial Health

How is Animalcare Group's financial position?


Financial Position Analysis

Short Term Liabilities: ANCR's short term assets (£29.8M) exceed its short term liabilities (£19.4M).

Long Term Liabilities: ANCR's short term assets (£29.8M) exceed its long term liabilities (£23.5M).


Debt to Equity History and Analysis

Debt Level: ANCR's debt to equity ratio (20.9%) is considered satisfactory.

Reducing Debt: ANCR's debt to equity ratio has reduced from 186.7% to 20.9% over the past 5 years.

Debt Coverage: ANCR's debt is well covered by operating cash flow (65.1%).

Interest Coverage: ANCR's interest payments on its debt are well covered by EBIT (5.3x coverage).


Balance Sheet


Dividend

What is Animalcare Group current dividend yield, its reliability and sustainability?

1.48%

Current Dividend Yield


Upcoming Dividend Payment

TodayApr 21 2021Ex Dividend DateJun 03 2021Dividend Pay DateJul 02 202129 days from Ex DividendBuy in the next 42 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: ANCR's dividend (1.48%) is higher than the bottom 25% of dividend payers in the UK market (1.34%).

High Dividend: ANCR's dividend (1.48%) is low compared to the top 25% of dividend payers in the UK market (4.1%).


Stability and Growth of Payments

Stable Dividend: ANCR has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: ANCR has only been paying a dividend for 3 years, and since then payments have not increased.


Current Payout to Shareholders

Dividend Coverage: With its high payout ratio (1026.7%), ANCR's dividend payments are not well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: ANCR's dividends in 3 years are forecast to be well covered by earnings (31.3% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.8yrs

Average management tenure


CEO

Jenny Winter (60 yo)

2.5yrs

Tenure

UK£370,000

Compensation

Ms. Jennifer Ann Julia Winter, also known as Jenny, BSc serves as Chief Executive Officer at Animalcare Group plc since October 01, 2018 and its Director at October 1, 2018. She served as Vice President of...


CEO Compensation Analysis

Compensation vs Market: Jenny's total compensation ($USD515.83K) is about average for companies of similar size in the UK market ($USD555.35K).

Compensation vs Earnings: Jenny's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: ANCR's management team is considered experienced (3.8 years average tenure).


Board Members

Experienced Board: ANCR's board of directors are considered experienced (3.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Animalcare Group plc's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Animalcare Group plc
  • Ticker: ANCR
  • Exchange: AIM
  • Founded: 1972
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: UK£160.953m
  • Shares outstanding: 60.06m
  • Website: https://www.animalcaregroup.co.uk

Number of Employees


Location

  • Animalcare Group plc
  • Unit 7, York Business Park
  • 10 Great North Way
  • York
  • North Yorkshire
  • YO26 6RB
  • United Kingdom

Listings


Biography

Animalcare Group plc engages in the development, sale, and distribution of licensed veterinary pharmaceuticals; and identification of products and services to companion animal veterinary markets in Spain, ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/04/20 18:46
End of Day Share Price2021/04/20 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.